Newron Pharmaceuticals SpA (NWRN) — Cash Flow Quality Index

Latest as of December 2024: -0.28x

Newron Pharmaceuticals SpA (NWRN) has a Cash Flow Quality Index of -0.28x as of December 2024. Operating cash flow of CHF-8.79 Million is below net income of CHF30.95 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Newron Pharmaceuticals SpA (NWRN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.28x
Operating CF / Net Income

Operating Cash Flow

CHF-8.79 Million
CHF

Net Income

CHF30.95 Million
CHF

Data as of

Dec 2024
Most recent filing

Newron Pharmaceuticals SpA Cash Flow Quality Index (2024–2024)

Historical Cash Flow Quality Index for Newron Pharmaceuticals SpA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Newron Pharmaceuticals SpA operating cash flow efficiency.

Annual Cash Flow Quality Index for Newron Pharmaceuticals SpA (2024–2024)

Year-by-year earnings quality comparison for Newron Pharmaceuticals SpA.

Year Quality Index Operating CF (CHF) Net Income YoY Change
2024 -0.82x CHF-17.61 Million CHF21.39 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.